Financial Statements

Thermo Fisher Scientific Inc. (TMO)


+4.99 (+0.92%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 28,11622,09218,69615,914-
Net Income 7,7256,3753,6962,9382,225
Stock Dividends -15-14-311013,926
Dividend Paid -395-337-297-266-237
Retained Earnings 35,43128,11622,09218,69615,914

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 5,9124,7494,1654,047-
Annual Depreciation 4,9442,6371,5108764,555
Capital Expenditure -2,523-1,474-926-758-508
Net PPE 8,3335,9124,7494,1654,047

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -25,29025,34725,71426,041
New Purchases -----
Intangible and Goodwill 25,29025,34725,71426,04141,924

Thermo Fisher Scientific Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Thermo Fisher Scientific Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.